Biotage AB (STU:PQX1) FCF Margin % : 13.96% (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Biotage AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biotage AB's Free Cash Flow for the three months ended in Mar. 2024 was €5.9 Mil. Biotage AB's Revenue for the three months ended in Mar. 2024 was €42.4 Mil. Therefore, Biotage AB's FCF Margin % for the quarter that ended in Mar. 2024 was 13.96%.

As of today, Biotage AB's current FCF Yield % is 2.29%.

The historical rank and industry rank for Biotage AB's FCF Margin % or its related term are showing as below:

STU:PQX1' s FCF Margin % Range Over the Past 10 Years
Min: 9.94 Med: 14.76 Max: 24.11
Current: 15.33

During the past 13 years, the highest FCF Margin % of Biotage AB was 24.11%. The lowest was 9.94%. And the median was 14.76%.

STU:PQX1's FCF Margin % is ranked better than
88.58% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs STU:PQX1: 15.33

Biotage AB FCF Margin % Historical Data

The historical data trend for Biotage AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB FCF Margin % Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

15.10

19.96

24.11

17.31

10.37

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-2.22	8.07	17.82	19.13	13.96

Competitive Comparison of Biotage AB's FCF Margin %

For the Medical Instruments & Supplies subindustry, Biotage AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biotage AB's FCF Margin % falls into.

Biotage AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biotage AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	17.254	/	166.457
	=	10.37 %

Biotage AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	5.92	/	42.415
	=	13.96 %

Biotage AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Biotage AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (STU:PQX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (STU:PQX1) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (STU:PQX1) Headlines

No Headlines